fluorescein-5-isothiocyanate has been researched along with Carcinoma, Pancreatic Ductal in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cabral, H; Iwata, C; Kano, MR; Miyazono, K; Morishita, Y; Sakai, S; Tanaka, HY | 1 |
1 other study(ies) available for fluorescein-5-isothiocyanate and Carcinoma, Pancreatic Ductal
Article | Year |
---|---|
Increased fibrosis and impaired intratumoral accumulation of macromolecules in a murine model of pancreatic cancer co-administered with FGF-2.
Topics: Albumin-Bound Paclitaxel; Animals; Antineoplastic Agents; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Collagen Type I; Dextrans; Disease Models, Animal; Fibroblast Growth Factor 2; Fibrosis; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Hydroxyproline; Male; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; RNA, Messenger; Xenograft Model Antitumor Assays | 2016 |